Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4707-50-0

Post Buying Request

4707-50-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4707-50-0 Usage

Uses

Divarinic Acid is an antibacterial compound that strongly inhibits bacterial growth of Bacillus subtilis, Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.

Check Digit Verification of cas no

The CAS Registry Mumber 4707-50-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,0 and 7 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4707-50:
(6*4)+(5*7)+(4*0)+(3*7)+(2*5)+(1*0)=90
90 % 10 = 0
So 4707-50-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H12O4/c1-2-3-6-4-7(11)5-8(12)9(6)10(13)14/h4-5,11-12H,2-3H2,1H3,(H,13,14)

4707-50-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,4-dihydroxy-6-propylbenzoic acid

1.2 Other means of identification

Product number -
Other names 2,4-Dihydroxy-6-propyl-benzoesaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4707-50-0 SDS

4707-50-0Relevant articles and documents

BIOENZYMATIC SYNTHESIS OF THC-v, CBV AND CBN AND THEIR USE AS THERAPEUTIC AGENTS

-

Paragraph 0154; 0155, (2017/10/18)

The present invention provides methods for producing cannabinoids. More specifically, the invention is directed to the bio-enzymatic synthesis of THC-v, CBV and CBN by contacting a compound according to Formula I with a cannabinoid synthase enzyme. Also described is a system for producing these pharmaceutically important cannabinoids and the use of such cannabinoids as therapeutic agents.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4707-50-0